![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 5/0783 | (2010.01) |
C12N 5/0646 | (2013.01) | ||
A61K 41/00 | (2020.01) | ||
A61K 41/0066 | (2013.01) | ||
A61K2239/31 | (2023.05) | ||
A61K 39/4611 | (2023.05) | ||
A61K2239/38 | (2023.05) | ||
A61K 39/4613 | (2023.05) | ||
A61K 39/46433 | (2023.05) | ||
A61K 39/4621 | (2023.05) |
(11) | Number of the document | 4077639 |
(13) | Kind of document | T |
(96) | European patent application number | 20833822.8 |
Date of filing the European patent application | 2020-12-17 | |
(97) | Date of publication of the European application | 2022-10-26 |
(45) | Date of publication and mention of the grant of the patent | 2024-06-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2020/086733 |
Date | 2020-12-17 |
(87) | Number | WO 2021/122969 |
Date | 2021-06-24 |
(30) | Number | Date | Country code |
19218724 | 2019-12-20 | EP |
(72) |
ZEISER, Robert , DE
APOSTOLOVA, Petya , DE
DUYSTER, Justus , DE
|
(73) |
Mallinckrodt Pharmaceuticals Ireland Limited ,
College Business & Technology Park
Cruiserath, Blanchardstown, Dublin 15,
IE
|
(54) | METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE |
METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE |